Clifton Streetscape will improve access, enhance aesthetics
|View larger image. The first part of phase 1 of the 10-phase project will begin sometime next month at Eagle Row and Clifton Road near WHSCAB.
Clifton Streetscape, a project to improve access, safety, and aesthetics along Clifton Road, is slated to begin next month (exact start date to be announced). Starting at Haygood Drive/Eagle Row and extending to North Decatur Road, it will include widening of the road and sidewalks, repaving of Clifton Road, new landscaping, and new access points to the Clifton corridor. The project will take approximately a year to complete and coincides with the opening of the J wing of Emory University Hospital (EUH).
Some specifics: An almost half-mile segment of Clifton Road will be resurfaced and widened, and a bike lane will be added along the east side—a "sharrow" or shared bike-vehicular lane will remain on the west side of Clifton Road. Sidewalks will be widened to eight feet, with addition of a five-foot planted strip along the curb, and trees and other plantings will be added to new medians. Street lights similar to those at Emory Village and Emory Point will be installed as well.
A new right-turn lane will be added at Clifton and North Decatur roads for westbound traffic headed toward Emory Village. A new traffic light and ingress/egress lanes also will be added at Healthgate Drive and North Decatur (currently a gated, limited access entry near the North Decatur Building). This access point will be for use primarily by Emory/Emory Healthcare faculty and staff who are accessing the parking decks along Gambrell Drive and is not intended for patients or through traffic.
These and other changes will help "calm traffic; improve safety for pedestrians, bikers, and drivers; and generally improve traffic flow for all those who travel Clifton Road each day," says Al Herzog, senior program manager for Campus Services. He adds that Clifton Streetscape is consistent with urban design guidelines developed with Emory several years ago by the Boston-based urban design firm, Goody Clancy, to provide a framework for more vibrant public areas on Clifton Road. Clifton Streetscape is being handled by JE Dunn Construction.
Separate but concurrent project affecting traffic: As part of the construction of the EUH J wing, a new pedestrian bridge is planned for installation over Clifton Road from the new J wing to EUH, starting in July. Later, the existing bridge will be removed. Bridge installation, being done by Gay Construction, will take place over a weekend and will necessitate restricted access to a portion of Clifton Road for that weekend. During that time, general traffic will be rerouted around the work site, and ambulances and emergency room visits will be accommodated.
Patience needed and appreciated: Both the bridge and Clifton Streetscape work will necessitate extended, periodic lane closures, although much of the road regrading and resurfacing work will be done at night and on weekends.
An Emory team is dedicated to keeping the Emory community, patients, visitors, and neighbors apprised of the work schedule and lane closures to minimize impact on travel and appointment times, says Herzog. Regular updates will appear in this publication and in Emory Report, and the CliftonStreetscape.com website will serve as an ongoing schedule resource.
Legislative session 2016
|Kallarin Mackey is director of state affairs, OGCA.
The Governor recently completed review of legislation passed during the 2016 Legislative Session. He vetoed 16 measures, including the religious liberty and campus carry legislation. While these dominated headlines, a number of less publicized health care bills of interest to Emory were considered this year:
HIV researchers were impacted by legislation clarifying existing law to allow minors to be tested for HIV without parental consent. This will allow researchers to gather critical data on the spread of HIV within this population.
Despite attempts to weaken the state's certificate of need (CON) process, the program remains unchanged. An effort to repeal the CON program lost steam early in the session. Legislative leaders are expected, however, to convene a working group in the months ahead to take a close look at the program. The Office of Government and Community Affairs (OGCA) will continue to closely monitor any CON-related activity and will coordinate with relevant business owners and legal staff.
In the months leading up to the session's start in January, the OGCA team began preparing for a state legislative response to fetal tissue research. A bill to prohibit the purchase or sale of fetal tissue in Georgia was introduced, and OGCA worked with Emory medical and legal representatives and external allies to ensure that the language drafted did not in any way impede Emory's research. The bill eventually stalled in the Senate Rules Committee.
In response to the backlog of rape kits found in some metro Atlanta hospitals, legislation was passed to establish uniform standards for the transfer of forensic medical exams from hospitals and rape crisis centers to law enforcement agencies. The bill requires law enforcement to pick up all rape kits within 96 hours from hospital and rape crisis centers, and those kits must be processed by law enforcement within 30 days. Some provisions of the underlying bill remain unclear with regard to administration of the new requirements. Legislation is expected to be introduced next year to clarify the law.
It was a relatively good budget year for health care. More than 30 primary care and Ob-Gyn codes will move to the Medicare rate in the FY 2017 budget, which takes effect July 1.
See OGCA's complete 2016 Implementation Report.
|Previously an orthopedic surgeon, Congressman Price did his residency at Emory and is a former faculty member.
Federal overview: On May 4, EVPHA Jon Lewin met with U.S. Rep. Tom Price (R-GA), Chairman of the U.S. House Budget Committee. President Wagner was also in the meeting. The conversation included discussion about economic modeling to reinforce the concept that research funding is beneficial to Georgia's economy. Following the meeting, Congressman Price spoke to a town hall meeting organized by the Emory Science Advocacy Network, a graduate student group that seeks to promote biomedical research funding through advocacy and education.
With floor time limited this year, congressional leaders are already looking ahead to 2017 and believe action could occur on entitlement reform and the Affordable Care Act next year. Still, there is a chance for passing bipartisan legislation this year on funding to combat the Zika virus, addressing opioid abuse, improving behavioral health services, and spurring medical innovation. Emory continues to advocate for increased research funding, reducing the administrative burden experienced by research institutions, flexible regulations for off-campus hospital outpatient departments, and the SMARTER Act, which would standardize hospital merger reviews between federal antitrust agencies.
Early results: care model for Medicare Advantage patients
An article published in the April 28 issue of NEJM Catalyst, outlines experiences thus far of a collaboration between Emory Healthcare and CareMore Health System to provide a population-based payment model for seniors.
As described in "One Path to Value-Based Care for Academic Health Systems," more than 13,500 older adult patients have enrolled in the coordinated care Emory Healthcare Network Advantage program. The network currently includes members from three insurance companies.
Two Emory Coordinated Care Centers opened in 2015 and are available to Emory’s Medicare Advantage patients who have an Emory primary care physician. The centers provide health care solutions for the complex problems of aging.
The article is co-authored by former and current EVPHAs Michael Johns and Jon Lewin with CareMore president, Sachin Jain.
According to Lewin, the population-based model, which entails risk-adjusted prepayment for provider services and 100% shared risk between providers and payers, was designed to focus on patients who have or are at risk for chronic conditions such as diabetes, congestive heart failure, or lung disease.
Early results from the collaboration have shown the following:
- Primary care capacity has increased because primary care physician (PCP) practices have fewer administrative responsibilities and thus more time for patients' acute care visits.
- Hospital readmission rates have decreased for patients who have been seen by an extensivist physician (who works in both outpatient and inpatient settings to provide comprehensive and coordinated care to patients with complex medical issues).
- Having a single operating model for all Medicare patients, rather than unique models for each Medicare Advantage payer and for traditional Medicare, has simplified processes for both PCPs and specialists.
The authors also discuss challenges they have encountered in launching the program, including acquiring sales and marketing expertise and acquainting providers with a model different from fee-for-service. Read more.
|Clostridium difficile, courtesy James Gathany, CDC
Measuring microbiome disruption: In a recent article in American Journal of Infection Control, infectious disease specialist Colleen Kraft and colleagues from Emory and CDC discuss the need for a microbiome disruption index to inform decisions on antibiotic stewardship and interventions such as fecal microbial transplant or oral probiotic capsules. They say that measures of microbiome diversity should assess several factors:
- Overall diversity: how much does one type of bacteria dominate
- Presence of bad guys, like C diff
- Presence of "keystone" species that prevent takeover by the bad guys
- Presence of bacteria thought to be beneficial or protective. Read more in Lab Land blog.
Heteroresistant bacteria: In a recent article in Nature Microbiology, scientists led by David Weiss, who leads the Emory Antibiotic Resistance Center, discuss strains of Enterobacter cloacae that are heteroresistant to the "last resort" antibiotic colistin. E cloacae has been causing an increasing number of infections in hospitals around the world.
Through heteroresistance, a subpopulation of antibiotic-resistant bacteria can lurk within a genetically identical crowd of antibiotic-susceptible bacteria. The phenomenon could be causing unexplained treatment failures in the clinic and highlights the need for more sensitive diagnostic tests.
The colistin-heteroresistant bacteria were isolated from blood or urine samples from patients at Atlanta hospitals.
"We are working on more sensitive diagnostic techniques, which would be required to catch strains like this in the clinic,” Weiss says.
Infectious disease experts were concerned about a November 2015 report from China of colistin resistance in another type of bacteria (Escherichia coli), because in that case, resistance was carried on a mobile piece of DNA, known as a plasmid, which can spread to other bacteria. Read more.